Waukesha, WI, -- GE Healthcare has become a contracted vendor for the ACC-NCDR Implantable Cardioverter Defibrillator (ICD) registry. Under the terms of the agreement, GE will develop software to allow institutions to send procedure data to the ACC-NCDR. The company also introduced new electronic forms that will expedite healthcare institution's participation in the ACC-NCDR ICD registry. The forms are a new feature on the MacLab Hemodynamic Monitoring and CardioLab Electrophysiology Monitoring systems, and will provide point-of-care data collection of ICD data for download to the ACC-NCDR ICD registry software. The registry software will enable the electronic submission of information that is now required by the centers for Medicare and Medicaid Services (CMS) for hospital compliance and reimbursement, a prerequisite included as part of the CMS 2005 decision to expand Medicare coverage of ICD procedures.

"GE is dedicated to the continued enhancement of patient care by participating in national database initiatives such as the ACC-NCDR ICD registry," said Mark Langer, general manager for Invasive Cardiology at GE Healthcare. "Our commitment to work with the ACC and Medicare to further promote patient safety and quality care is just one example of GE's vision to re-imagine healthcare."

GE anticipates that the ACC-NCDR ICD registry software will be certified during the fourth quarter of 2006.


About GE Healthcare:

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform and treat disease, so their patients can live their lives to the fullest. GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases, and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $15 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 43,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit www.gehealthcare.com

Back to HCB News

More Industry Headlines